Analyst firms · Morgan Stanley · IRTC
Morgan Stanley IRTC price target and rating history
iRhythm Holdings Inc. (IRTC) · Health Care
Morgan Stanley rates iRhythm Holdings Inc. (IRTC) Overweight with a $151 price target, as of its latest action on Feb 24, 2022. It has published 4 rating actions on IRTC since November 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.
- Current rating
- Overweight
- Price target
- $151
- Median target, all firms
- $160
- Actions on IRTC
- 4
Morgan Stanley price target on IRTC
Every Morgan Stanley rating on IRTC
- Feb 24, 2022
- Jan 18, 2022
- Jan 7, 2022
- Nov 8, 2021
How other firms rate IRTC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Neutral | $124 | Nov 6, 2026 |
| Piper Sandler | Overweight | $160 | Oct 16, 2026 |
| Stephens | Overweight | $160 | Jul 23, 2026 |
| Evercore ISI | Outperform | $210 | Jan 5, 2026 |
Questions about Morgan Stanley and IRTC
- What is Morgan Stanley's price target for IRTC?
- Morgan Stanley's latest stated price target for iRhythm Holdings Inc. (IRTC) is $151, from its action on Feb 24, 2022.
- What is Morgan Stanley's rating on IRTC?
- Morgan Stanley rates IRTC Overweight, a bullish rating, as of Feb 24, 2022.
- When did Morgan Stanley last change its view on IRTC?
- On Feb 24, 2022, Morgan Stanley cuts its price target to $151 from $167, keeps Overweight.
- How does Morgan Stanley's IRTC target compare with other analysts?
- Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.
More IRTC rating histories
All Morgan Stanley ratingsIRTC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.